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Abstract
Background: There is a degree of dissonance between the types of evaluative research required
by organisations providing or commissioning health care, those recommended by organisations
developing evidence-based guidance, and those which research funding bodies are prepared to
support.
Methods: We present a case study of efforts to establish a pragmatic but robust evaluation of local
exercise referral schemes. We considered the epidemiological, ethical and practical advantages and
disadvantages of a number of study designs and applied for research funding based on an
uncontrolled design, outlining the difficulties of carrying out a randomised controlled trial to
evaluate an existing service.
Results:  Our proposal was praised for its relevance and clear patient outcomes, but the
application was twice rejected because both funders and reviewers insisted on a randomised
controlled trial design, which we had found to be impractical, unacceptable to service users and
potentially unethical.
Conclusion: The case study highlights continuing challenges for applied public health research in
the current funding climate.
Background
Primary Care Trusts (PCTs) must demonstrate that the
health services they purchase on behalf of their popula-
tions are effective and cost-effective [1]. One source of
guidance in this area is the National Institute for Health
and Clinical Excellence (NICE), which issues evidence-
based guidance on promoting good health and preventing
and treating ill-health in England. NICE supports the
commissioning of evidence-based care by issuing national
guidance based on the best available evidence of effective-
ness and cost-effectiveness [2]. The production and imple-
mentation of NICE guidance reflects an increasing
recognition of the importance of an evaluative culture in
the NHS [3] which has also resulted in several well-estab-
lished services coming under increasing evaluative scru-
tiny. However, there is a degree of dissonance between the
types of evaluative research required by organisations pro-
viding or commissioning health care, those recom-
mended by organisations developing evidence-based
guidance, and those which research funding bodies are
prepared to support.
To take one example, exercise referral schemes -- intended
to help prevent and treat conditions associated with sed-
entary lifestyles, such as obesity -- have been widely
adopted in the UK. Sowden and Raine note that '...these
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schemes were encouraged to expand by the Department of
Health (DH) before DH-funded evaluations had reported
their findings and with little reference to NICE recom-
mendations' [4]. However, there are few published or
ongoing evaluation studies of such schemes and a recent
Cochrane review found that the quality of randomised tri-
als in this area was generally poor [5]. The limitations
identified included high attrition rates, short follow-up
periods, a lack of objective measurement of physical activ-
ity and limited objective data on health outcomes. On the
basis of the available evidence, NICE issued a recommen-
dation in 2006 that practitioners, policy makers and com-
missioners should neither endorse nor refer people to
exercise referral schemes to promote physical activity
unless those schemes were 'part of a properly designed
and controlled research study to determine effectiveness'
[6,7].
Anecdotal evidence suggests that this guidance was inter-
preted in some PCTs as advice to disinvest in all exercise
referral schemes which were not part of such a study. In
2007 the DH therefore issued a clarification, emphasising
that PCTs should continue to provide high quality exer-
cise referral schemes for the medical management of con-
ditions such as type 2 diabetes, obesity and osteoporosis,
while acknowledging that further research was required to
determine the impact of exercise referral schemes on
health inequalities and their effectiveness in increasing
physical activity levels in adult populations [8].
A service-academic partnership in Cambridgeshire was
charged with developing a pragmatic but robust evalua-
tion of existing local exercise referral schemes to improve
targeting of the service and guide NHS spending priorities
in light of the NICE guidance and a climate of financial
constraint. The aim was not simply to evaluate effective-
ness, but also to assess whether schemes were delivering as
expected and how their impact could be enhanced, for
example by improving targeting, uptake and other aspects
of implementation. This dual aim reflected an aspiration
that a service-academic partnership in public health
should be capable of carrying out evaluative research that
can both contribute to the global evidence base for the
effectiveness of interventions and serve the evidential
needs of commissioners of local services. In this case study
we report and reflect on the challenges of attempting to
design, execute and fund the type of study which appeared
to have been called for and discuss the implications for
researchers, research funders, service commissioners and
the producers of evidence-based guidance.
Case study
We aimed to assess whether exercise referral was associ-
ated with improvements in participants' self-reported and
objectively-measured physical activity and anthropomet-
ric, physiological and other measures of health status after
completion of the scheme (12 weeks) and in the longer
term (one year), thereby addressing many of the identi-
fied limitations of previous research [5]. Leisure centre
staff were trained in anthropometric, physical activity and
fitness measurement and standardised equipment and
operating procedures were used to ensure valid and relia-
ble data collection. We also aimed to understand how
effective the service was in practice, and how its targeting,
uptake and implementation could be improved, by
assessing who was being referred, the reasons for referral,
completion rates, and the socio-demographic and other
characteristics of completers, non-completers and those
who derived most benefit.
Mindful of NICE's stipulation of a 'properly designed and
controlled' study [6], we considered the trade-offs
between a variety of 'ideal' and pragmatic study designs
[9] and between the competing merits of internal validity
(minimising bias and confounding within the study) and
external validity (producing findings applicable to the
local context and the population at large). A randomised
controlled trial (RCT) would have ensured that interven-
tion and control groups were comparable on baseline
characteristics, and process measures could have been col-
lected as part of such a trial. However, we were concerned
about the ethical implications of removing an established
service and restarting it as a trial, as well as enrolling par-
ticipants in a study in which they would have had to
accept a 50% chance of not joining an existing exercise
referral scheme, given that they had recently been identi-
fied as in need of a tailored exercise programme. Consul-
tations with exercise referral staff and service users
confirmed that even if this design had involved randomi-
sation to a waiting list rather than a no-intervention con-
trol group, this would have been unacceptable to
participants, resulting in low recruitment and impaired
retention in the control group with the associated risk of
bias and limited external validity. Indeed, the difficulties
in recruiting and maintaining a control group randomised
to a waiting list are well described by Isaacs et al in their
single-centre RCT of an exercise referral programme in
Barnet, outer London [10].
A non-randomised controlled study would have
addressed the ethical concerns associated with randomi-
sation. A control group with a similar socio-demographic
and health profile to that of the intervention group would
have been recruited from the local community. The con-
trol group would have undergone the same measurements
and follow-up as the intervention group but would not
have received the tailored exercise programme. However,
patients referred to exercise referral schemes do not con-
stitute a homogeneous group which can readily be
'matched' in aggregate, but reflect a diverse range of med-
ical histories and socio-demographic backgrounds, and
even if a comparable control group could have been con-BMC Public Health 2009, 9:362 http://www.biomedcentral.com/1471-2458/9/362
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structed according to these parameters, it is likely that
people who take part in such a scheme differ in important
ways from those with similar medical and socio-demo-
graphic characteristics who do not engage with this type of
service [11]. In addition, there would have been little
incentive for individuals to enter the control arm of such
a study if they had no chance of receiving the service or if
they were to be added to a long waiting list. Identifying
and recruiting a suitable comparison group would there-
fore have been difficult and might have introduced selec-
tion and response bias.
We therefore selected an uncontrolled before-and-after
cohort design as the most feasible and ethically acceptable
study design in the situation. Although this design would
have had lower internal validity, making it more difficult
to attribute any observed changes in health status to exer-
cise referral alone, it would have had strong external valid-
ity in terms of assessing the targeting, uptake,
implementation and impact of local schemes. We secured
ethical approval for this study design and applied for local
National Institute for Health Research (NIHR) funding for
the study, outlining the difficulties of carrying out an RCT
to evaluate an existing NHS service. Our proposal was
praised for its relevance and clear patient outcomes, but
both the funding body and the external referees insisted
on a randomised controlled trial design comparing exer-
cise referral with no exercise referral and the proposal was
twice rejected. Since none of the local partner organisa-
tions was able to fund the study, it was abandoned follow-
ing successful completion of a pilot study.
Discussion
In trying to establish this study, we faced both service
challenges (promoting a research culture among exercise
referral staff, and engaging GPs and practice managers)
and academic challenges (selecting an appropriate design
and securing funding). It was potentially difficult, for
example, to work as part of a team evaluating a service
when the employment of some of the wider stakeholders
was potentially dependent on the continuation of the
service. Furthermore, while feedback from the funding
body praised our proposal as being relevant with clear
patient outcomes, the referees also insisted on a ran-
domised controlled design, which we had found on con-
sideration to be impractical and unacceptable to service
users, and potentially compromised by limitations to
internal and external validity. We were also concerned
with the ethics of deliberately withholding an established
NHS service. Sowden and Raine [4] concur with our find-
ings by arguing that the experimental evaluation of exer-
cise referral in England is now unlikely because of the
widespread assumption of effectiveness, the comprehen-
sive coverage of the schemes, the indirect adverse conse-
quences of dismantling the schemes, and the lack of
appropriate process and outcome data.
Our experience thus suggests a degree of dissonance
between the types of research required by the NHS, those
recommended by NICE, and those which research fund-
ing bodies are prepared to support. This reflects a central
tension in intervention research in public health between
the need to establish evidence of the efficacy of an inter-
vention under ideal conditions and the need to under-
stand whether a potentially efficacious intervention is
actually effective in practice and how its implementation
can be optimised. Research funding bodies have tradition-
ally supported the former, 'purer' type of research rather
than the evaluation of services as 'real world' interven-
tions [12].
Which study designs are appropriate for applied public 
health research?
Some funders or peer reviewers may start from the
assumption that an RCT is what is required, instead of
starting by asking 'What is the research question?' fol-
lowed by 'What is the most appropriate study design to
answer that question in this context?' RCTs are rightly
regarded as the gold standard for evaluating efficacy, but
their utility for addressing questions in public health
intervention research is not universally or uncritically
accepted [13]. Macintyre and Petticrew describe a com-
mon misconception '...that it is adequate to know that
some intervention does good in general, and that it is not
necessary to know how much good, at what cost, via what
mechanisms, or for which subgroups of the popula-
tion'[14]. Answers to these latter questions may be partic-
ularly important to policy makers and commissioners, for
whom evidence-based public health must rely on a variety
of types of evidence, including that from qualitative and
observational studies [4,15,16]. In addition, RCTs usually
start from an assumption of equipoise -- i.e. a position of
not knowing which of two competing interventions is
more effective, or not knowing whether an intervention is
likely to be beneficial or harmful [17] -- but this position
is not clear with regards to exercise referral schemes. For
instance, in a recent systematic review based on 18 studies
(including six RCTs), exercise referral was shown to have
a small but significant effect on increasing physical activ-
ity in some people [18]. While this suggests that equipoise
may no longer be an issue, the small effect size and poor
quality of many of the studies included in the review, as
well as the lack of data on cost-effectiveness, indicates that
the situation is not straightforward. Conversely, given that
there is evidence for benefit in some people, there may
not be enough equipoise to remove an established exer-
cise referral service and restart it as a trial. The authors rec-
ommended that more research was needed to understand
uptake and adherence, and also suggested the use of well-
conducted qualitative studies. Furthermore, although
physical activity has been consistently shown to be impre-
cisely measured by self-report [19], none of the RCTs in
the systematic review incorporated objective measure-BMC Public Health 2009, 9:362 http://www.biomedcentral.com/1471-2458/9/362
Page 4 of 5
(page number not for citation purposes)
ment, a limitation which our proposed study design
would have overcome.
The limitations of observational studies of exercise referral
schemes are well known, including moderate participa-
tion rates, lack of long-term follow-up and poor compli-
ance [18]. However, methodologically weaker RCTs (for
example, those with small numbers of participants, low
and differential retention rates, imprecise outcome meas-
ures and lack of attention to allocation concealment)
should not necessarily "trump" methodologically
stronger observational studies [20]. Many RCTs have
highly selective inclusion criteria, and even among the eli-
gible population have low recruitment rates (if indeed
they are even reported), leading to unrepresentative study
samples. In the context of exercise referral schemes, peo-
ple who agree to be randomised to the possibility of not
receiving the service, or who agree to allow their GP to
refer them to such a trial, are likely to be systematically
different from the population who might participate in
this type of intervention outside the setting of an RCT, and
the service settings in which an RCT is permitted to take
place are likely to be systematically different from those in
which the service providers decline to permit an RCT.
There is clearly a spectrum from efficacy to effectiveness,
and an apparent trade-off between internal and external
validity. As such, the choice of study design should not be
considered the sole criterion of quality. Indeed, the qual-
ity of individual studies is now receiving greater emphasis
in the formulation of evidence-based guidance than was
originally the case [21].
In general, there is a need to broaden the scope of the cri-
teria that are used to appraise and evaluate public health
interventions, including the use of qualitative and obser-
vational data [4,15,16]. In some situations, as with our
proposed evaluation of an existing service, an RCT maybe
neither an ethical nor a pragmatic choice, nor does it nec-
essarily provide the most relevant information or the most
unbiased estimates of effects. Evidence-based public
health must therefore rely on a variety of types of evi-
dence, often in combination. As Victora et al state "...ran-
domisation, without further analyses for adequacy and
plausibility, is never sufficient to support public health
decision-making, regardless of the level of statistical sig-
nificance achieved" [13].
Who should specify and fund applied public health 
research?
In the wake of the Cooksey report on the funding of
health research [22] and the formation of the Office for
Strategic Coordination of Health Research (OSCHR),
there is some confusion as to what constitutes public
health research in the UK and who should be funding it.
The new NIHR public health research programme goes
some way towards addressing the need for more applied
intervention studies outside the NHS, but much public
health research appears at risk of falling through the
cracks between the slabs of 'basic' research (the responsi-
bility of the Medical Research Council) and 'applied' and
clinical research (the responsibility of NIHR), or of being
assessed against criteria more applicable to 'basic'
research, in which the main currency of success tends to
be the number and 'quality' of research publications. Suc-
cessful translational or applied public health research is
more appropriately characterised by evidence of a subse-
quent change in practice or service provision and transla-
tion into population health gain -- outcomes which are
likely to depend on greater communication and collabo-
ration between academic partners and those defining serv-
ice needs to make research projects a success. In light of
our experience, we would therefore advocate opportuni-
ties for greater dialogue between applicants for funding
and those reviewing, awarding and advocating research
funding (except where applications have no merit at all).
This would promote a more thoughtful consideration of
the feasibility of what the referees are suggesting and the
development of study designs that are acceptable to
research participants, users, and funders.
Opportunities for greater dialogue should also extend to
producers of evidence-based guidance such as NICE.
There is no mechanism for ensuring that NICE research
recommendations are acted upon, and while not all
funders will share NICE's research priorities, perhaps deci-
sions by NHS funding bodies should be more closely
informed by them. Bidding for funds is always competi-
tive and many factors contribute to a decision to rate some
proposals more highly than others. Producers of guid-
ance, and commissioners and practitioners receiving guid-
ance should have due regard for the quality and quantity
of the evidence underpinning recommendations before
acting on them, since guidance development groups
working on public health topics are often in the difficult
position of having to make recommendations based on
limited evidence. It may also be helpful for bodies issuing
evidence-based guidance, such as NICE, to specify accept-
able study designs in their recommendations for further
research, make clear the conditions under which interven-
tions should or should not be implemented, and explain
what health care providers should do while the research
called for is being completed. In this context, where a rec-
ommendation is made not to offer an intervention out-
side the setting of a controlled research study because
evidence for its effectiveness is described as 'equivocal', it
should be made clear whether the equivocation is
between a beneficial effect and a harmful effect (in which
case the condition of equipoise may be satisfied) or
between a beneficial effect and no effect (in which case the
condition of equipoise may not be satisfied and commis-
sioners may reasonably decide, in the absence of a more
effective alternative course of action, to give existing serv-BMC Public Health 2009, 9:362 http://www.biomedcentral.com/1471-2458/9/362
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ices the benefit of the doubt until the evidence base is
populated with stronger evidence either way). Costs
should also be considered when describing results as
equivocal. If a service or the evaluation of a service is
extremely expensive, this may also affect the condition of
equipoise.
Summary
There is a degree of dissonance between the types of eval-
uative research required by organisations providing or
commissioning health care, those recommended by
organisations developing evidence-based guidance, and
those which research funding bodies are prepared to sup-
port. Applied public health research may face an uncertain
future until we are clear about the level and type of evi-
dence that is sufficient to inform NICE guidelines and jus-
tify the provision of health services, and we have the scale
and availability of research funding to meet these require-
ments.
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